siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells

W Zhou, J Wang, WY Man, QW Zhang… - Asian Pacific Journal of …, 2015 - koreascience.kr
W Zhou, J Wang, WY Man, QW Zhang, WG Xu
Asian Pacific Journal of Cancer Prevention, 2015koreascience.kr
Clinical resistance to chemotherapeutic agents is one of the major hindrances in the
treatment of human cancers. EHZ2 is involved in drug resistance and is overexpressed in
drug-resistant cancer cell lines. In this study, we investigated the effects of EHZ2 on cisplatin-
resistance in A549/DDP and AGS/DDP cells. EHZ2 mRNA and protein were found to be
significantly overexpressed in A549/DDP and AGS/DDP cells, compared to parental cells.
EHZ2 siRNA successfully silenced EHZ2 mRNA and protein expression. Proliferation was …
Abstract
Clinical resistance to chemotherapeutic agents is one of the major hindrances in the treatment of human cancers. EHZ2 is involved in drug resistance and is overexpressed in drug-resistant cancer cell lines. In this study, we investigated the effects of EHZ2 on cisplatin-resistance in A549/DDP and AGS/DDP cells. EHZ2 mRNA and protein were found to be significantly overexpressed in A549/DDP and AGS/DDP cells, compared to parental cells. EHZ2 siRNA successfully silenced EHZ2 mRNA and protein expression. Proliferation was inhibited and drug resistance to cisplatin was improved. Flow cytometry showed that silencing of EHZ2 arrested A549/DDP and AGS/DDP cells in the G0/G1 phase, increasing apoptosis, rh-123 fluorescence intensity and caspase-3/8 activities. Silencing of EHZ2 also significantly reduced the mRNA and protein expression levels of cyclin D1 and MDR1, while up-regulating p15, p21, p27 and miR-218 in A549/DPP cells. Furthermore, silencing of EHZ2 also significantly increased the expression level of tumor suppressor factor miR-218. We also found down-regulating EHZ2 expression increased methylation in A549/DDP and AGS/DDP cells. This study demonstrates that drug resistance can be effectively reversed in human cisplatin-resistant lung and gastric cancer cells through delivery of siRNAs targeting EHZ2.
koreascience.kr